DPP-IV inhibitor-associated arthralgias

Endocr Pract. 2013 Mar-Apr;19(2):377. doi: 10.4158/EP13076.LT.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Activities of Daily Living
  • Arthralgia / chemically induced*
  • Arthralgia / physiopathology
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Drug Monitoring
  • Drug Therapy, Combination / adverse effects
  • Humans
  • Male
  • Metformin / therapeutic use
  • Middle Aged
  • Pyrazines / adverse effects
  • Pyrazines / therapeutic use
  • Severity of Illness Index
  • Sitagliptin Phosphate
  • Treatment Outcome
  • Triazoles / adverse effects
  • Triazoles / therapeutic use

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Pyrazines
  • Triazoles
  • Metformin
  • Sitagliptin Phosphate